NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2
Authors
Keywords
miR-30b, NF-κB, Cardiac apoptosis, Bcl-2
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 387, Issue 1-2, Pages 135-141
Publisher
Springer Nature
Online
2013-10-31
DOI
10.1007/s11010-013-1878-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-30b-5p Is Involved in the Regulation of Cardiac Hypertrophy by Targeting CaMKIIδ
- (2016) Juan He et al. JOURNAL OF INVESTIGATIVE MEDICINE
- A functional genomics screen for microRNA regulators of NF-kappaB signaling
- (2013) Anthony O Olarerin-George et al. BMC BIOLOGY
- Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
- (2013) Evangelos Oikonomou et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis
- (2012) G. Bridge et al. BLOOD
- NF-κB mediated miR-26a regulation in cardiac fibrosis
- (2012) Chuanyu Wei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
- (2012) Takehiro Ichikawa et al. PLoS One
- Thymosin Beta 4 Protects Cardiomyocytes from Oxidative Stress by Targeting Anti-Oxidative Enzymes and Anti-Apoptotic Genes
- (2012) Chuanyu Wei et al. PLoS One
- Cardiomyocyte-specific I B kinase (IKK)/NF- B activation induces reversible inflammatory cardiomyopathy and heart failure
- (2012) H. J. Maier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of MicroRNAs in Cardiac Remodeling and Heart Failure
- (2011) Veli K. Topkara et al. CARDIOVASCULAR DRUGS AND THERAPY
- BCL2A1: the underdog in the BCL2 family
- (2011) M Vogler CELL DEATH AND DIFFERENTIATION
- MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop
- (2011) Lili Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNAs in NF- B signaling
- (2011) X. Ma et al. Journal of Molecular Cell Biology
- Role of nuclear factor κB in cardiovascular health and disease
- (2010) Kim van der Heiden et al. CLINICAL SCIENCE
- Heat shock protein 90 regulates IκB kinase complex and NF-κB activation in angiotensin II-induced cardiac cell hypertrophy
- (2010) Kyung Hye Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells
- (2010) Rui Zhou et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs in Cardiac Apoptosis
- (2010) Peifeng Li Journal of Cardiovascular Translational Research
- MicroRNAs in Cardiac Remodeling and Disease
- (2010) Zhan-Peng Huang et al. Journal of Cardiovascular Translational Research
- NF- B activation is required for adaptive cardiac hypertrophy
- (2009) L. Zelarayan et al. CARDIOVASCULAR RESEARCH
- Targeted Deletion of Nuclear Factor κB p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
- (2009) Leo Timmers et al. CIRCULATION RESEARCH
- Apoptosis: a potentially reversible, meta-stable state of the heart
- (2008) Carolina Masri et al. HEART FAILURE REVIEWS
- Blockade of NF-κB Using IκBα Dominant-Negative Mice Ameliorates Cardiac Hypertrophy in Myotrophin-Overexpressed Transgenic Mice
- (2008) David Young et al. JOURNAL OF MOLECULAR BIOLOGY
- Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κB
- (2007) Sudhiranjan Gupta et al. JOURNAL OF MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started